JPMorgan Chase & Co’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.8K | Buy |
6,263
+6,084
| +3,399% | +$45.4K | ﹤0.01% | 5121 |
|
|
2025
Q1 | $1.75K | Hold |
179
| – | – | ﹤0.01% | 5690 |
|
|
2024
Q4 | $968 | Sell |
179
-13
| -7% | -$70 | ﹤0.01% | 5686 |
|
|
2024
Q3 | $1.21K | Sell |
192
-14,561
| -99% | -$91.6K | ﹤0.01% | 5631 |
|
|
2024
Q2 | $93.4K | Buy |
14,753
+9,588
| +186% | +$60.7K | ﹤0.01% | 4623 |
|
|
2024
Q1 | $42.4K | Buy |
5,165
+263
| +5% | +$2.16K | ﹤0.01% | 5031 |
|
|
2023
Q4 | $40.9K | Hold |
4,902
| – | – | ﹤0.01% | 5064 |
|
|
2023
Q3 | $63.2K | Sell |
4,902
-558
| -10% | -$7.19K | ﹤0.01% | 4828 |
|
|
2023
Q2 | $87.2K | Buy |
+5,460
| New | +$87.2K | ﹤0.01% | 4693 |
|